Virginia Retirement Systems Et Al Crispr Therapeutics Ag Transaction History

Virginia Retirement Systems Et Al

$10.1 Billion
Q3 2023

A detailed history of Virginia Retirement Systems Et Al transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 21,400 shares of CRSP stock, worth $960,860. This represents 0.01% of its overall portfolio holdings.

Number of Shares

21,400

Previous 11,800 81.36%

Holding current value

$960,860

Previous $662,000 46.68%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Jan 02, 2024	BUY	$45.39 - $59.0 $435,744 - $566,400	9,600 Added 81.36%	21,400 $971,000
Q2 2023 Aug 22, 2023	BUY	$43.47 - $67.77 $191,268 - $298,188	4,400 Added 59.46%	11,800 $662,000
Q1 2023 Jul 11, 2023	BUY	$41.0 - $56.12 $303,400 - $415,288	7,400 New	7,400 $334,000
Q3 2022 May 16, 2023	SELL	$61.1 - $83.78 $281,060 - $385,388	-4,600 Reduced 25.27%	13,600 $889 Million
Q1 2022 Apr 21, 2022	BUY	$53.19 - $79.24 $58,509 - $87,164	1,100 Added 6.43%	18,200 $1.14 Million
Q4 2021 Feb 03, 2022	BUY	$70.09 - $111.29 $126,162 - $200,322	1,800 Added 11.76%	17,100 $1.3 Million
Q3 2021 Oct 21, 2021	BUY	$110.2 - $156.64 $980,780 - $1.39 Million	8,900 Added 139.06%	15,300 $1.71 Million
Q2 2021 Aug 13, 2021	SELL	$100.84 - $161.89 $60,504 - $97,133	-600 Reduced 8.57%	6,400 $1.04 Million
Q1 2021 Apr 30, 2021	BUY	$110.72 - $210.04 $276,800 - $525,100	2,500 Added 55.56%	7,000 $853,000
Q4 2020 Feb 16, 2021	SELL	$79.67 - $173.23 $844,502 - $1.84 Million	-10,600 Reduced 70.2%	4,500 $689,000
Q3 2020 Nov 12, 2020	BUY	$78.5 - $100.64 $62,800 - $80,512	800 Added 5.59%	15,100 $1.26 Million
Q2 2020 Aug 12, 2020	BUY	$38.5 - $76.05 $15,400 - $30,420	400 Added 2.88%	14,300 $1.05 Million
Q1 2020 May 12, 2020	BUY	$33.68 - $62.53 $468,152 - $869,167	13,900 New	13,900 $589,000

Others Institutions Holding CRSP

# of Institutions

523

Shares Held

58M

Call Options Held

1.73M

Put Options Held

1.84M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.5B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Account

Virginia Retirement Systems Et Al Crispr Therapeutics Ag Transaction History